Apimeds Pharmaceuticals US, Inc. (APUS) income statement
APUSNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.60−0.14 (-8.05%)
Close on Nov 20, 2026Market cap $2.41MP/E –Yield –
Apimeds Pharmaceuticals US, Inc. financial ratios
See a number that looks wrong?